Fatigue in multiple sclerosis presenting as acute relapse: Subjective and objective assessment

Multiple Sclerosis

Volumn 14, Issue 2, 2008, Pages 274-277

  Flachenecker, Peter ^a   Meissner, Heike ^a  

^a Neurological Rehabilitation Center Quellenhof   (Germany)

Author keywords

attention; fatigue; multiple sclerosis; neuropsychological tests; questionnaires; relapse

Indexed keywords

CORTICOSTEROID; GADOLINIUM; METHYLPREDNISOLONE; OLIGOCLONAL BAND; REBOXETINE;

ADULT; ALERTNESS; ARM; ARTICLE; ATTENTION; BEHAVIOR THERAPY; CASE REPORT; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DYSESTHESIA; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPESTHESIA; LIMB PAIN; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESTHESIA; RELAPSE; TENDON REFLEX; TREATMENT OUTCOME; WHITE MATTER;

EID: 43149102538     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458507082480     Document Type: Article

References (11)

1. Krupp L. Fatigue is intrinsic to multiple sclerosis (MS) and is the most commonly reported symptom of the disease. Mult Scler 2006; 12: 367-8.
2. Flachenecker P., Kümpfel T., Kallmann B., Gottschalk M., Grauer O., Rieckmann P. et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523-6.
3. Comi G., Leocani L., Rossi P., Colombo B. Physiopathology and treatment of fatigue in multiple sclerosis. J Neurol 2001; 248: 174-9.
4. Schwid SR, Covington M., Segal BM, Goodman AD Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 2002; 39: 211-4.
5. Flachenecker P., Müller G., König H., Meissner H., Toyka KV, Rieckmann P. 'Fatigue' bei multipler Sklerose: Entwicklung und Validierung des 'Würzburger Erschöpfungs-Inventar bei Multiper Sklerose' (WEIMuS). Nervenarzt 2006; 77: 165-72.
6. Zimmermann P., Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Psytest-Verlag, Herzogenrath, 1995.
7. Krupp LB, Rizvi SA Symptomatic therapy for under-recognized manifestations of multiple sclerosis. Neurology 2002; 58 (suppl 4): S32-9.
8. Krupp LB, Elkins LE Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000; 55: 934-9.
9. Schwid SR, Tyler CM, Scheid EA, Weinstein A., Goodman AD, McDermott MP Cognitive fatigue during a test requiring sustained attention: a pilot study. Mult Scler 2003; 9: 503-8.
10. Sheean GL, Murray NM, Rothwell JC, Miller DH, Thompson AJ An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis. Brain 1998; 121: 967-75.
11. Van Zomeren AH, Brouwer WH Clinical neuropsychology of attention. Oxford University Press, New York, 1994.